Cited by 595Chemokine receptors and signalinginterferon and immune responsesSystemic Lupus Erythematosus Research

Chemokine (C–X–C motif) ligand (CXCL)10 in autoimmune diseases

Antonelli, Alessandro, Ferrari, Silvia Martina, Giuggioli, Dilia, Ferrannini, Ele, Ferri, Clodoveo, Fallahi, Poupak·2014·Autoimmunity Reviews

Abstract

(C-X-C motif) ligand (CXCL)10 (CXCL10) belongs to the ELR(-) CXC subfamily chemokine. CXCL10 exerts its function through binding to chemokine (C-X-C motif) receptor 3 (CXCR3), a seven trans-membrane receptor coupled to G proteins. CXCL10 and its receptor, CXCR3, appear to contribute to the pathogenesis of many autoimmune diseases, organ specific (such as type 1 diabetes, autoimmune thyroiditis, Graves' disease and ophthalmopathy), or systemic (such as rheumatoid arthritis, psoriatic arthritis, systemic lupus erythematosus, mixed cryoglobulinemia, Sjögren syndrome, or systemic sclerosis). The secretion of CXCL10 by cluster of differentiation (CD)4+, CD8+, natural killer (NK) and NK-T cells is dependent on interferon (IFN)-γ, which is itself mediated by the interleukin-12 cytokine family. Under the influence of IFN-γ, CXCL10 is secreted by several cell types including endothelial cells, fibroblasts, keratinocytes, thyrocytes, preadipocytes, etc. Determination of high level of CXCL10 in peripheral fluids is therefore a marker of host immune response, especially T helper (Th)1 orientated T-cells. In tissues, recruited Th1 lymphocytes may be responsible for enhanced IFN-γ and tumor necrosis factor-α production, which in turn stimulates CXCL10 secretion from a variety of cells, therefore creating an amplification feedback loop, and perpetuating the autoimmune process. Further studies are needed to investigate interactions between chemokines and cytokines in the pathogenesis of auto…

Integrity signals

Registry

Crossref · 10.1016/j.autrev.2013.10.010

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Many of the changes in the circulating proteome in people with Down syndrome are highly reminiscent of those observed in type I interferonopathies and other autoinflammatory conditions.

    “Our study of the circulating proteome in people with DS, the largest and most comprehensive study of this kind reported to date, reveals that T21 causes profound immune dysregulation, with many of the changes being highly reminiscent of those observed in type I interferonopathies and other autoinflammatory conditions54,58–60,88 (Table 1).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Antonelli, A., Ferrari, S. M., Giuggioli, D., Ferrannini, E., Ferri, C., & Fallahi, P.
Affiliations
  • University of Pisa (IT)
  • University of Modena and Reggio Emilia (IT)
Corresponding author
Antonelli, Alessandro
Venue
Autoimmunity Reviews
Publisher
Elsevier BV
Published
2014-03
Volume
13
Issue
3
Pages
272-280
ISSN
1568-9972 (ISSN-L)
OpenAlex
W2006821600
Cited by
595
References
3
Citations by year
2026: 33 · 2025: 53 · 2024: 62 · 2023: 50 · 2022: 53 · 2021: 56 · 2020: 45 · 2019: 35 · 2018: 35 · 2017: 51 · 2016: 46 · 2015: 41 · 2014: 34
FWCI
4.26
Type
journal article
Language
en
Open access
closed
Locations
  • Autoimmunity Reviews (publishedVersion)
  • PubMed (publishedVersion)
  • CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
  • IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
  • Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
  • Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
Keywords
CXCL10, CXCR3, chemokines, autoimmune disease, interferon-gamma, Th1 cells, IL-12, type 1 diabetes, autoimmune thyroiditis, Graves' disease, rheumatoid arthritis, systemic lupus erythematosus, Sjögren's syndrome, systemic sclerosis, mixed cryoglobulinemia, biomarkers, therapeutic target
MeSH terms
Animals, Autoimmune Diseases, Humans, Inflammation, Ligands, Chemokine CXCL10, Receptors, CXCR3

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review